Sanofi upgraded to hold by Deutsche Bank
Deutsche Bank has upgraded Sanofi (NASDAQ:SNY) to hold from sell, citing the company's Q4 earnings report. The investment ...
Deutsche Bank posts steeper-than-expected Q4 profit fall and scraps cost target
Legal provisions weighed on the bottom line at Germany’s largest lender Deutsche Bank, with net profit falling in the fourth ...
Sanofi upgraded to Hold at Deutsche Bank after ‘solid’ Q4 report
Deutsche Bank upgraded Sanofi (SNY) to Hold from Sell with a price target of EUR 100, up from EUR 85, following the company’s “solid” Q4 ...
Deutsche Bank: Bullish, But No Longer All-In
Deutsche Bank reported solid Q4 results with €7.2 billion in revenue, driven by a 30% YoY jump in the investment bank. Read more about DB stock here.
Investing9d
Deutsche Bank maintains Celanese stock Buy rating ahead of Q4 results
Tuesday, Deutsche Bank (ETR:DBKGn) analysts maintained a Buy rating on shares of Celanese Corporation (NYSE:CE) with a steady price target of $85.00. The firm anticipates the forthcoming Q4 ...
Deutsche Bank’s Heavier Costs Drag Shares Despite Investment Bank Strength
The lender’s better-than-expected performance in investment banking was overshadowed by a drop in profit and shares slumped ...
Deutsche Bank: 35% Tangible Book Discount Even As Company Confirms 2025 Targets
Deutsche Bank derives 57% of its revenue from the Private Bank and Corporate Bank segments which saw weaker Q4 2024 profitability. Learn more on DB stock here.